Mount Sinai Hospital

In November 2017, Compugen announced a multi-year research collaboration with Mount Sinai Hospital, under the direction of Miriam Merad M.D., Ph.D., Director of the Precision Immunology Institute and Co-Leader of the Cancer Immunology program and Mount Sinai Professor in Cancer Immunology at the Icahn School of Medicine at Mount Sinai in New York, and a member of Compugen’s Scientific Advisory Board. The collaboration focuses on the research and validation of selected myeloid candidate programs discovered by Compugen based on their potential for cancer immunotherapy treatments.

APPLY TO THIS POSITION


Max 1mb, accepted formats: pdf, doc, docx, rtf
Message Sent. Thank You!

RELATED DOCUMENTS